4basebio PLC (88Q.DE) XETRA
6.15
-0.85(-12.14%)
Currency In EUR
- General
- Statistics
- Historical Data
- Profile
- Financials
4basebio PLC
Address
25 Norman Way
Cambridge,
United Kingdom of Great Britain and Northern Ireland (the)
Phone
+44 1223 967943
Website
Sector
Healthcare
Industry
Biotechnology
Employees
101
First IPO Date
November 23, 2021
Key Executives
| Name | Title | Pay | Year Born |
| Amy Walker | CEO & Director | 356,301 | 1993 |
| Manja Hermina Elisabeth Maria Boerman | Executive Chair of the Board | 0 | 1966 |
| Christine Wolosin | Chief Commercial Officer | 0 | N/A |
| Scott Lorimer | Chief Operating Officer | 0 | N/A |
| Jennifer Gelman | Vice President of Marketing | 0 | N/A |
Description
4basebio Plc is a biotechnology company, which engages in the business of developing advanced therapy medicinal products through synthetic DNA products and non-viral, cell targeting nucleic acid delivery platforms. The firm is involved in manufacturing and supplying high quality synthetic DNA products for research, therapeutic, and pharmacological use; and developing target specific non-viral vectors for the efficient delivery of payloads in patients. The company was founded on December 22, 2020 and is headquartered in Cambridge, the United Kingdom.
